News

Vico Therapeutics, a Dutch biotech company focusing on the development of RNA modulating therapies for rare neurological disorders, has raised $31 million in Series A financing.

Cambridge, Massachusetts-based Omega Therapeutics, a genomic medicine company, has raised $85 million in financing.

Washington, D.C.-based Aquicore, a platform for digitizing real estate operations and optimizing buildings, has secured $14 million in funding.

Heal, a health tech startup, has raised $100 million in funding.

South San Francisco-based Nura Bio Inc, a biopharma company focused on developing neuroprotective drugs, has raised $73 million in Series A funding.

Eargo, a medical device company, has secured $71 million in financing.

Ermetic, a cloud access risk security company, has raised $17.25 million in Series A financing.

Seattle-based Polyarc, an AR game developer, has secured $9 million in Series B funding.

Paris-based DNA Script, a DNA synthesis company, has raised $50 million as an extension to its Series B funding, expanding the round to $89 million.

Cambridge, Massachusetts and Baltimore-based Thrive Earlier Detection Corp, a healthcare company focused on incorporating earlier cancer detection into routine medical care, has raised $257 million in Series B financing.